When is it acceptable to use a strong anion exchange HPLC column in place of a weak anion exchange column? Is it ever acceptable?
An LCGC reader recently submitted the following question:
When is it acceptable to use a strong anion exchange HPLC column in place of a weak anion exchange column? Is it ever acceptable?
The following answer was provided by Tom Jupille, president of LC Resources, Inc. (Walnut Creek, California).
The short answer: If you can demonstrate that it works, then it's acceptable . . . but don't hold your breath; you're unlikely to make it work without modifying other parameters such as pH, ionic strength, or mobile phase salt type.The longer answer: the terms "strong" and "weak" refer to the pKa of an ion exchanger, just as they do to any acid or base. A strong exchanger has a very low (acid) or high (base) pKa, and is therefore completely ionized at any reasonable intermediate pH. Examples would be sulfonate ("S") cation exchangers or quaternary ammonium ("Q") anion exchangers. A weak exchanger has an intermediate pKa; the degree of ionization varies over a 3-4 pH unit range around the pKa. Examples would be carboxymethyl (CM) cation exchangers or diethlyaminoethyl (DEAE) anion exchangers."Strong" and "weak" are often confused with "high capacity" and "low capacity." The capacity of an ion exchanger is the amount of charge per unit volume of column packing. It is quite possible to have a low-capacity strong exchanger or a high-capacity weak exchanger. The difference is that the capacity of a weak exchanger can be pH-dependent.If the operating pH of the method is near the pKa of a weak exchanger, then the chances of matching the ion exchange capacity in a strong exchanger range from slim to none. Even if you do match the capacity, secondary factors such as substrate chemistry, charge density of the ligand, and so forth come into play and make an exact match extremely difficult (in fairness, those same factors would apply even when substituting another weak exchanger).
Questions?
LCGC technical editor Steve Brown will answer your technical questions. Each month, one question will be selected to appear in this space, so we welcome your submissions. Please send all questions to the attention of "Ask the Editor" at lcgcedit@lcgcmag.com We look forward to hearing from you.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Investigating Plastic Contamination in Olive Oil with GC–MS/MS
January 17th 2025The objective of this study was to investigate contamination by 32 plasticizers in olive oil throughout its production and packaging process. Separation and detection were carried out by gas chromatography tandem mass spectrometry (GC–MS/MS), without the need for pre-concentration steps.
Top Execs from Agilent, Waters, and Bruker Take the Stage at J.P. Morgan Healthcare Conference
January 16th 2025The 43rd Annual Healthcare J.P. Morgan Healthcare Conference kicked off in San Francisco earlier this week. Here’s what top executives from Agilent, Bruker, and Waters, discussed during the event.